Search

everythinglearnresearchcommunity

for

Search:↓

Traditional Chinese medicine may help treat ischemic stroke by targeting specific genes and pathways.

Hair restoration can be achieved through non-surgical treatments like minoxidil, antiandrogens, phototherapy, and PRP procedures, or through surgical methods like hair transplantation. Continued treatment is needed to maintain results, and full results are visible after 12-18 months.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

Adipose tissue changes in obesity can trigger stress in fat cells.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Tralokinumab for atopic dermatitis may cause side effects like dizziness, headache, nausea, hair loss, and acne.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

TGF-β inhibitors may help treat liver fibrosis by targeting various pathways.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Alopecia areata affects quality of life more in adolescents than adults.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Alopecia can often be managed effectively with various treatments, but early diagnosis is crucial for preventing permanent hair loss.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.